Behrens, C., Arnold, B., & Krammer, P. H. (2001). CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice. The journal of immunology, 166(5), . https://doi.org/10.4049/jimmunol.166.5.3240
Chicago-Zitierstil (17. Ausg.)Behrens, Christian, Bernd Arnold, und Peter H. Krammer. "CD95 Ligand-expressing Tumors Are Rejected in Anti-tumor TCR Transgenic Perforin Knockout Mice." The Journal of Immunology 166, no. 5 (2001). https://doi.org/10.4049/jimmunol.166.5.3240.
MLA-Zitierstil (9. Ausg.)Behrens, Christian, et al. "CD95 Ligand-expressing Tumors Are Rejected in Anti-tumor TCR Transgenic Perforin Knockout Mice." The Journal of Immunology, vol. 166, no. 5, 2001, https://doi.org/10.4049/jimmunol.166.5.3240.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.